Role of Wound Irrigation After Appendectomy

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT03773224
Collaborator
(none)
179
1
2
9.2
19.4

Study Details

Study Description

Brief Summary

Surgical site infection is a common problem after open appendectomy. Irrigation of the surgical wound by topical antibiotics has been devised as a measure to reduce the incidence of wound infection. The present trial aims to assess the efficacy of layer-by-layer wound irrigation with gentamicin-saline solution in prevention of superficial surgical site infection after open appendectomy for acute uncomplicated appendicitis.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Irrigation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
179 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Trial on Wound Irrigation in Prevention of Surgical Site Infection After Appendectomy
Actual Study Start Date :
Dec 20, 2018
Actual Primary Completion Date :
Aug 1, 2019
Actual Study Completion Date :
Sep 27, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Irrigation

Layer by layer irrigation of the surgical wound with gentamicin-saline solution

Procedure: Irrigation
upon closure of the peritoneum gentamicin-saline solution (160 mg of gentamicin in 400 ml of normal saline 0.9%) will be used for irrigation of every layer of the wound before its closure

No Intervention: Control

The surgical wound is closed layer by layer without irrigation

Outcome Measures

Primary Outcome Measures

  1. Surgical site infection [2 months after surgery]

    The incidence of superficial site infection as detected by clinical examination on follow-up

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients of both genders aging between 18 and 65 years who present with acute appendicitis.

  • Patients with perforated appendicitis will be also included.

Exclusion Criteria:
  • Patients with appendicular mass, appendicular abscess, generalized peritonitis.

  • Patients with other causes of acute abdomen as revealed intraoperatively.

  • Patients taking long course of steroid therapy or immunosuppressive treatment,

  • Patients unwilling to participate in the trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mansoura university hospital Mansourah Dakahlia Egypt

Sponsors and Collaborators

  • Mansoura University

Investigators

  • Study Chair: Sameh H Emile, Mansoura University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sameh Emile, Lecturer of general surgery, Mansoura University
ClinicalTrials.gov Identifier:
NCT03773224
Other Study ID Numbers:
  • mansoura67
First Posted:
Dec 12, 2018
Last Update Posted:
May 27, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 27, 2020